Pictet Asset Management
MANE

Pictet Asset Management’s Veradermics Inc MANE Stock Holding History

Pictet Asset Management’s Portfolio MANE Stock Details MANE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$251K Buy
+2,042
New +$191K ﹤0.01% 1867

Other funds holding MANE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
FMI
F/M Investments Washington, District of Columbia $1.97B AUM 30.33% 1-Year Est. Return

Pictet Asset Management's MANE Position: Q2 2026 in Review

Pictet Asset Management opened a new position in Veradermics Inc (MANE) in Q2 2026: 2,042 shares worth $251K. The stake represents ﹤0.01% of the portfolio and ranks #1867 among its holdings.

49 funds tracked by Wall St. Rank hold MANE as of Q2 2026.

  • Pictet Asset Management held 2,042 shares of Veradermics Inc worth $251K as of Q2 2026.
  • Veradermics Inc was a new Pictet Asset Management position in Q2 2026.
  • Veradermics Inc made up ﹤0.01% of Pictet Asset Management's portfolio in Q2 2026, its #1867 holding.
  • 49 funds tracked by Wall St. Rank held Veradermics Inc as of Q2 2026.

Based on Pictet Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.